Zusammenfassung
In den folgenden Abschnitten werden die verschiedenen Formen der obstruktiven Atemwegserkrankungen erläutert, die je nach Alter, prädisponierenden Risikofaktoren und auch je nach Art der Auslöser verschiedenartige Ausprägungen und Verlaufsformen (Phänotypen) annehmen können.
Chapter PDF
Similar content being viewed by others
Literatur
Einführung
Brand PL, Baraldi E, Bisgaard H et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidencebased approach. Eur Respir J 2008; 32(4): 1096–1110
Frey U, Suki B. Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control. Lancet 2008; 20; 372 (9643): 1088–99
Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med 2009; 360: 2130–2133
Akute virale Bronchiolitis
American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 2006; 118: 1774–1793
Barben J, Hammer J. Behandlung der Bronchiolitis im Suglingsalter - Empfehlungen der SAPP Paediatrica 2003; 14: 18–21
Barben J, Kuehni CE, Trachsel D, Hammer J. Management of acute bronchiolitis: Can evidence-based guidelines alter clinical practice? Thorax 2008; 63(12): 1103–1109
Calogero C, Sly P. Acute virale bronchiolitis: To treat or not to treat - that is the question. J Pediatr 2007; 151(3): 235–237
Cunningham S, McMurray A. Observational study of two oxygen saturation targets for discharge in bronchiolitis. Arch Dis Child 2012; 97(4): 361–363
Fernandes RM, Bialy LM, Vandermeer B, et al. Glucocorticoids for acute viral bronchiolitis in infants and young children. Cochrane Database Syst Rev 2010; 10: CD00487–8
Gadomski AM, Brower M. Bronchodilators for bronchiolitis. Cochrane Database Syst Rev 2010; 12: CD00126–6
Hammer J, Numa A, Newth CJL. Acute respiratory distress syndrome induced by respiratory syncytial virus. Pediatr Pulmonol 1997; 23: 176–183
Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2011; 360(6): 588–598
Kimpen JLL, Hammer J. Bronchiolitis in infants. Eur Respir Mon 2006; 37: 170–190
Midulla F, Scagnolari C, Bonci E, et al. Respiratory syncytial virus, human bocavirus and rhinovirus bronchiolitis in infants. Arch Dis Child 2011; 95(1): 35–41
Levin D, Tribuzio M, Green-Wrzesinki T, et al. Empiric antibiotics are justified for infants with respiratory syncytial virus lower respiratory tract infection presenting with respiratory failure: a prospective study and evidence review. Pediatr Crit Care Med 2010; 11(3): 390–395
Wainwright C. Acute viral bronchiolitis in children - a very common condition with few therapeutic options. Paediatr Respir Rev 2010; 11(1): 39–45
Wright M, Piedimonte G. Respiratory syncytial virus prevention and therapy: past, present, and future. Pediatr Pulmonol 2011; 46(4): 324–347
Obstruktive Bronchitis
Brand PL, Baraldi E, Bisgaard H et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidencebased approach. Eur Respir J 2008; 32(4): 1096–1110
Bush A. Diagnosis of asthma in children under five. Prim Care Respir J 2007; 16: 7–15
Ducharme FM, Lemire C, Noya FJ et al. Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N Engl J Med 2009; 360: 339–353
Frey U, von Mutius E. The challenge of managing wheezing in infants. N Engl J Med 2009; 360: 2130–2133
Kieninger E, Fuchs O, Latzin P et al. Rhinovirus infections in infancy and early childhood. Eur Respir J 2013; 41(2): 443–52
Leonardi NA, Spycher BD, Strippoli MP et al. Validation of the Asthma Predictive Index and comparison with simpler clinical prediction rules. J Allergy Clin Immunol 2011; 127: 1466–1472
Panickar JR, Grigg J. Controversies in the management of preschool viral wheeze. Paediatr Respir Rev 2006; 7: 293–298
Panickar J, Lakhanpaul M, Lambert PC et al. Oral prednisolone for preschool children with acute virus-induced wheezing. N Engl J Med 2009; 360: 329–338
Robertson CF, Price D, Henry R et al. Short-course montelukast for intermittent asthma in children: a randomized controlled trial. Am J Respir Crit Care Med 2007; 175(4): 323–329
Asthma bronchiale
Bisgaard H, Bonnelykke K. Long-term studies of the natural history of asthma in childhood. J Allergy Clin Immunol 2010; 126: 187–197
Cookson W, Moffatt M, Strachan DP. Genetic risks and childhood-onset asthma. J Allergy Clin Immunol 2011; 128(2): 266-70; quiz 271–2
de Groot EP, Duiverman EJ, Brand PL. Comorbidities of asthma during childhood: possibly important, yet poorly studied. Eur Respir J 2010; 36(3): 671–8
Ege MJ et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med 2011; 364(8): 701–9
Galli SJ, Tsai M, Piliponsky AM. The development of allergic inflammation. Nature 2008; 454(7203): 445–54
Holgate ST. Innate and adaptive immune responses in asthma. Nat Med 2012; 18(5): 673–83
Jackson DJ, Gangnon RE, Evans MD et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med 2008; 178(7): 667–72
Jorgensen IM et al. Asthma Mortality in the Danish Child Population. Pediatr Pulmonol 2003; 36: 142–147
Lai CKW et al. Global variation in the prevalence and severity of asthma symptoms. Thorax 2009; 64(6): 476–83
Ogden CL, et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006; 295(13): 1549–55
Pearce N et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC). Thorax 2007; 62: 758–766
Phelan P et al. The Melbourne Asthma Study: 1964-1999. Journal Allergy Clin Immunol 2002; 109 (2): 189–94
Scholtens S et al. Overweight and changes in weight status during childhood in relation to asthma symptoms at 8 years of age. J Allergy Clin Immunol 2009; 123(6): 1312-8 e–2.
Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med 2009; 15(1): 39–45
www.ginasthma.com
Klinik
Agache I et al. Untangling asthma phenotypes and endotypes. Allergy 2012
Anderson SD. How does exercise cause asthma attacks? Current Opinion in Allergy and Clinical Immunology 2006; 6: 37–42
Becker JM. Asthma deaths during sports: report of a 7-year experience. J Allergy Clin Immunol 2004; 113: 264–267
Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926–938
Brand PL et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J 2008; 32(4): 1096–110
Busse WW, Lemanske RF, Jr., Gern JE. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376(9743): 826–34
Guilbert TW. Identifying and managing the infant and toddler at risk for asthma. J Allergy Clin Immunol 2010; 126(2): 417–22
Hedlin G, Bush A, Lødrup Carlsen K, et al. Problematic severe asthma in children, not one problem but many: a GA2LEN initiative. Eur Respir J 2010; 36(1): 196–201
Illi S et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet 2006; 368(9537): 763–70
Korn S, Hübner M, Hamelmann E, Buhl R. The German Severe Asthma Registry. Pneumologie 2012; 66(6): 341–4
Randoph C. Exercise-induced Bronchospasm in Children. Clinic Rev Allerg Immunol 2008; 34: 205–216
Regamey N, Casaulta Aebischer C, Frey U. Acute asthma attacks in childhood. Ther Umsch 2005; 62(8): 539–42
Rosenstein N et al. The common cold-principles of judicious use of antimicrobial agents. Pediatrics 1998; 101(1): 181–184
Diagnostik
Empfehlungen zur Behandlung der obstruktiven Atemwegserkrankungen im Kindesalter (SGPP/PIA 2009 Schweiz). Paediatrica 2009; 20, 3: 44–50
Nationale Versorgungsleitlinie Asthma Langfassung, 2. Auflage, Version 1.3, Juli 2011, http://www.versorgungsleitlinien.de/themen/asthma/pdf/nvl_asthma_lang.pdf
Österreichische Leitlinien - Riedler et al. Wien Klin Wochenschr 2008
Therapie
Global Initiative for Asthma (GINA). The Global Strategy for Asthma Management and Prevention. 2007 [cited: 2010 Nov 19]. Available from: http://www.ginasthma.com/download.asp?intId=309
Kleine-Tebbe J et al. Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen, Leitlinien der Deutschen Gesellschaft Allergologie und klinische Immunologie (DGAKI), des Ärzteverbandes Deutscher Allergologen (ÄDA), der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA), der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI) und der Schweizerischen Gesellschaft für
Allergologie und Immunologie (SGAI). Allergo J 2009; 18: 508–37
Lemanske RF Jr, Mauger DT, Sorkness CA et al. Childhood Asthma Research and Education (CARE) Network of the National Heart, Lung, and Blood Institute: Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. N Engl J Med 2010; 362: 975–85
Nationale Versorgungsleitlinie Asthma Langfassung, 2. Auflage, Version 1.3, Juli 2011, http://www.versorgungsleitlinien.de/themen/ asthma/pdf/nvl_asthma_lang.pdf
National Heart, Lung and Blood Institute (NHLBI). Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Full Report 2007. 2007 [cited: 2010 Nov 19]. Available from: http:// www.nhlbi.nih.gov/guidelines/asthma/asthgdln.pdf
Riedler J, Eber E, Frischer T et al. Leitlinie zur Behandlung des Asthma bronchiale bei Kindern und Jugendlichen. Wien Klin Wochenschr 2008; 120: 54–60
Roth S, Barrazzone C, Barben J et al. Empfehlungen zur Behandlung der obstruktiven Atemwegserkrankungen im Kindesalter (SGPP/ PIA-CH 2009). Paediatrica 2009; 20: 44–51
Krupp-Syndrom/Epiglottitis
Bjornson CL, Johnson DW. Croup. Lancet 2008; 371: 329-339. Review
Bjornson C, Russel KF, Vandermeer B et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev 2011; 16(2): CD00661–9
Moore M, Little P Humidified air inhalation for treating croup: a systematic review and meta-analysis. Fam Pract 2007; 24(4): 295–301
Nicolai T, Mutius E von. Risk of asthma in children with a history of croup. Acta Paediatr 1996; 85: 1295–1299
Roorda RJ, Walhof CM. Effect of inhaled fluticasone propionate administered with metered dose inhaler and spacer in mild to moderate croup: a negative preliminary report. Pediatric Pulmonology 1998; 25: 114–117
Russell KF, Liang Y, O´Gorman K et al. Glucocorticoids for croup. Cochrane Database Syst Rev 2011; 19(1): CD00195–5
Van Bever HP, Wieringa, Weyler JJ et al. Croup and recurrent croup: their association with asthma and allergy. An epidemiological study on 5-8-year-old children. Eur. J Pediatr 1999; 158: 253–257
Waisman Y, Klein BL, Boenning DA et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89: 302–306
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Frey, U. et al. (2013). Obstruktive Atemwegserkrankungen. In: von Mutius, E., Gappa, M., Eber, E., Frey, U. (eds) Pädiatrische Pneumologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-34827-3_27
Download citation
DOI: https://doi.org/10.1007/978-3-642-34827-3_27
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-34826-6
Online ISBN: 978-3-642-34827-3
eBook Packages: Medicine (German Language)